Bryan A Faller

Summary

Affiliation: Fox Chase Cancer Center
Country: USA

Publications

  1. pmc Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancer
    Bryan A Faller
    Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Clin Med Insights Oncol 5:131-44. 2011
  2. doi request reprint Images in clinical medicine. New-onset clubbing associated with lung cancer
    Bryan A Faller
    Washington University School of Medicine, St Louis, MO 63110, USA
    N Engl J Med 359:e15. 2008
  3. doi request reprint Therapy-related acute myelogenous leukemia with an 11q23/MLL translocation following adjuvant cisplatin and vinorelbine for non-small-cell lung cancer
    Bryan A Faller
    Department of Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Clin Lung Cancer 10:438-40. 2009

Collaborators

Detail Information

Publications3

  1. pmc Safety and efficacy of vinorelbine in the treatment of non-small cell lung cancer
    Bryan A Faller
    Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Clin Med Insights Oncol 5:131-44. 2011
    ..Its safety has been well established with neutropenia, anemia, nausea, and vomiting being the most frequently encountered toxicities. The data defining the risks and benefits of vinorelbine in the treatment of NSCLC will be summarized...
  2. doi request reprint Images in clinical medicine. New-onset clubbing associated with lung cancer
    Bryan A Faller
    Washington University School of Medicine, St Louis, MO 63110, USA
    N Engl J Med 359:e15. 2008
  3. doi request reprint Therapy-related acute myelogenous leukemia with an 11q23/MLL translocation following adjuvant cisplatin and vinorelbine for non-small-cell lung cancer
    Bryan A Faller
    Department of Hematology and Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA 19111, USA
    Clin Lung Cancer 10:438-40. 2009
    ..To our knowledge, this is the first case of therapy-related acute myelogenous leukemia (t-AML) associated with this chemotherapy combination. The literature on t-AML with the 11q23/MLL rearrangement is reviewed...